O'Connor Daniel J. Insider Trades

Insider Trading History

Track insider trading activity for O'Connor Daniel J.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
DiaMedica Therapeutics
DiaMedica Therapeutics DMAC
Director
Holding Value $375k 64,242 shares
Last Trade
Feb 20, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$425k 64,242 shares
$6.61
$5.84
Seelos Therapeutics
Seelos Therapeutics SEEL
Director
Holding Value $616 1,666 shares
Last Trade
Jan 04, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$284k 1,666 shares
$170.24
$0.37
Ambrx Biopharma
Ambrx Biopharma AMAM
President And CEO
Holding Value $38.2M 1,363,332 shares
Last Trade
Dec 11, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.24M 750,000 shares
$12.32
$28.00
Ambrx Biopharma
Ambrx Biopharma AMAM
President And CEO
Holding Value $9.6M 342,845 shares
Last Trade
Oct 27, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$491k 50,012 shares
$9.82
$28.00
Ambrx Biopharma
Ambrx Biopharma AMAM
President And CEO
Holding Value $34.1M 1,216,500 shares
Last Trade
Jul 05, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20.2M 1,216,500 shares
$16.60
$28.00
Ambrx Biopharma
Ambrx Biopharma AMAM
President And CEO
Holding Value $77M 2,750,000 shares
Last Trade
Apr 26, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$25M 2,750,000 shares
$9.08
$28.00
Seelos Therapeutics
Seelos Therapeutics SEEL
Director
Holding Value $18.5k 50,000 shares
Last Trade
Jan 05, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$156M 50,000 shares
$3,113.51
$0.37
Ambrx Biopharma
Ambrx Biopharma AMAM
President And CEO
Holding Value $0 0 shares
Last Trade
Jan 01, 2023 Sale
$12.3M 5,410,000 shares
$2.27
$28.00
ZyVersa Therapeutics
ZyVersa Therapeutics ZVSA
Director
Holding Value $241k 1,377,598 shares
Last Trade
Dec 12, 2022 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
No data
No data
$0.18
ZyVersa Therapeutics
ZyVersa Therapeutics ZVSA
Director
Holding Value $306 1,750 shares
Last Trade
Dec 12, 2022 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
No data
No data
$0.18
ZyVersa Therapeutics
ZyVersa Therapeutics ZVSA
Director
Holding Value $31k 177,204 shares
Last Trade
Dec 12, 2022 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
No data
No data
$0.18
Seelos Therapeutics
Seelos Therapeutics SEEL
Director
Holding Value $5.92k 16,000 shares
Last Trade
Jun 01, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$37.1M 16,000 shares
$2,318.22
$0.37
ZyVersa Therapeutics
ZyVersa Therapeutics ZVSA
Chief Executive Officer
Holding Value $35.2k 201,239 shares
Last Trade
Jan 06, 2022 Sale (Other)Another type of insider transaction reported on SEC Form 4.
No data
No data
$0.18
ZyVersa Therapeutics- Units (1 Ord Share Class A & 3/4 War)
ZyVersa Therapeutics- Units (1 Ord Share Class A & 3/4 War) LSPRU
Chief Executive Officer
Holding Value $874k 42,005 shares
Last Trade
Jan 06, 2022 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$421k 42,005 shares
$10.02
$20.80
ZyVersa Therapeutics- Units (1 Ord Share Class A & 3/4 War)
ZyVersa Therapeutics- Units (1 Ord Share Class A & 3/4 War) LSPRU
Chief Executive Officer
Holding Value $4.19M 201,239 shares
Last Trade
Jan 06, 2022 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$235k 23,404 shares
$10.02
$20.80
ZyVersa Therapeutics- Units (1 Ord Share Class A & 3/4 War)
ZyVersa Therapeutics- Units (1 Ord Share Class A & 3/4 War) LSPRU
Chief Executive Officer
Holding Value $874k 42,005 shares
Last Trade
Jan 06, 2022 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$421k 42,005 shares
$10.02
$20.80
Larkspur Health Acquisition
Larkspur Health Acquisition LSPR
Chief Executive Officer
Holding Value $4.53M 201,239 shares
Last Trade
Jan 06, 2022 Sale (Other)Another type of insider transaction reported on SEC Form 4.
No data
No data
$22.50
ZyVersa Therapeutics- Units (1 Ord Share Class A & 3/4 War)
ZyVersa Therapeutics- Units (1 Ord Share Class A & 3/4 War) LSPRU
Chief Executive Officer
Holding Value $4.2M 201,848 shares
Last Trade
Jan 06, 2022 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$6.1k 609 shares
$10.02
$20.80
ZyVersa Therapeutics- Units (1 Ord Share Class A & 3/4 War)
ZyVersa Therapeutics- Units (1 Ord Share Class A & 3/4 War) LSPRU
Chief Executive Officer
Holding Value $4.2M 201,848 shares
Last Trade
Jan 06, 2022 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$6.1k 609 shares
$10.02
$20.80
ZyVersa Therapeutics- Units (1 Ord Share Class A & 3/4 War)
ZyVersa Therapeutics- Units (1 Ord Share Class A & 3/4 War) LSPRU
Chief Executive Officer
Holding Value $4.19M 201,239 shares
Last Trade
Jan 06, 2022 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$235k 23,404 shares
$10.02
$20.80

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up